BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15031882)

  • 21. Cardiovascular effects of ephedra.
    Krantz MJ
    JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069036
    [No Abstract]   [Full Text] [Related]  

  • 22. Herbal supplements may require modifications of dental treatment.
    Abebe W
    Dent Today; 2009 Jan; 28(1):136-7. PubMed ID: 19323340
    [No Abstract]   [Full Text] [Related]  

  • 23. JAMA patient page. Ephedra and ephedrine.
    Torpy JM; Lynm C; Glass RM
    JAMA; 2003 Mar; 289(12):1590. PubMed ID: 12672776
    [No Abstract]   [Full Text] [Related]  

  • 24. Banning ephedra: good call, poor vision.
    Gordon JS
    Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrocardiographic effects of a dietary supplement containing ephedra and caffeine.
    Milic M; Rizos D; Ziegler MG
    JAMA; 2005 Sep; 294(12):1487; author reply 1487-8. PubMed ID: 16189358
    [No Abstract]   [Full Text] [Related]  

  • 26. Addressing the potential risks associated with ephedra use: a review of recent efforts.
    Schulman S
    Public Health Rep; 2003; 118(6):487-92. PubMed ID: 14563905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary thrombosis related to use of Xenadrine RFA.
    Sachdeva R; Sivasankaran S; Fishman RF; Zarich SW; McPherson CA
    Tex Heart Inst J; 2005; 32(1):74-7. PubMed ID: 15902827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ephedra/ephedrine: cardiovascular and CNS effects.
    Wooltorton E; Sibbald B
    CMAJ; 2002 Mar; 166(5):633. PubMed ID: 11898947
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular effects of ephedra alkaloids: a comprehensive review.
    Andraws R; Chawla P; Brown DL
    Prog Cardiovasc Dis; 2005; 47(4):217-25. PubMed ID: 15991150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
    Maglione M; Miotto K; Iguchi M; Jungvig L; Morton SC; Shekelle PG
    Am J Psychiatry; 2005 Jan; 162(1):189-91. PubMed ID: 15625222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Share your herbal supplement use with your doctor. Research shows that some popular supplements may be dangerous for people with cardiovascular diseases.
    Heart Advis; 2010 Apr; 13(4):6-7. PubMed ID: 23043208
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers.
    Gardner SF; Franks AM; Gurley BJ; Haller CA; Singh BK; Mehta JL
    Am J Cardiol; 2003 Jun; 91(12):1510-3, A9. PubMed ID: 12804749
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of Ephedra-containing products and risk for hemorrhagic stroke.
    Morgenstern LB; Viscoli CM; Kernan WN; Brass LM; Broderick JP; Feldmann E; Wilterdink JL; Brott T; Horwitz RI
    Neurology; 2003 Jan; 60(1):132-5. PubMed ID: 12525737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Tag--we're it".
    Czap A
    Altern Med Rev; 2003 May; 8(2):104. PubMed ID: 12777156
    [No Abstract]   [Full Text] [Related]  

  • 35. Ephedra: heart dangers in disguise.
    Consum Rep; 2004 Jan; 69(1):22-3. PubMed ID: 14677546
    [No Abstract]   [Full Text] [Related]  

  • 36. Case report: Consequences of ephedra use in an athlete.
    Libman RB; Menna BL; Gulati S
    Lancet; 2005 Dec; 366 Suppl 1():S22. PubMed ID: 16360736
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA issues alert on ephedra supplements in the USA.
    Nelson R
    Lancet; 2004 Jan; 363(9403):135. PubMed ID: 14733193
    [No Abstract]   [Full Text] [Related]  

  • 38. Regarding the cardiovascular effects of an herbal ephedra-caffeine weight loss product.
    Rawson ES; Persky AM
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1353-4. PubMed ID: 15052276
    [No Abstract]   [Full Text] [Related]  

  • 39. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
    Haller CA; Benowitz NL
    N Engl J Med; 2000 Dec; 343(25):1833-8. PubMed ID: 11117974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasospasm and stroke attributable to ephedra-free xenadrine: case report.
    Holmes RO; Tavee J
    Mil Med; 2008 Jul; 173(7):708-10. PubMed ID: 18700609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.